Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
If severe nausea persists for more than 48 hours or you cannot keep any fluids down, contact your healthcare provider
Holman RR, Bethel MA, Mentz RJ, et al
Additionally, in the OASIS 1 trial (19), oral semaglutide at a dose of 50 mg, which is not yet available for clinical use in obesity or type 2 diabetes, induced an average of 15% weight loss, with 85% of participants achieving at least 5% weight loss (compared to 26% with placebo) and 54% achieving at least 15% weight loss
Collaborative Care Coordination between endocrinologists and cardiologists is vital for patients with heart conditions: Shared Care Plans: Ensures holistic management of diabetes and cardiovascular health
Beyond glycemic control, the pleiotropic actions of GLP-1 on various organs and metabolic pathways are emphasized, underscoring its potential utility in addressing cardiovascular, renal, and obesity-related complications
